1-hydroxymethylmidazolam has been researched along with 1-triacontanol in 1 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (1-triacontanol) | Trials (1-triacontanol) | Recent Studies (post-2010) (1-triacontanol) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 67 | 0 | 31 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Deng, S; Fan, A; Gao, W; Li, C; Li, N; Liu, Q; Wang, C; Wen, X; Zhang, Q; Zhang, W; Zhang, Y; Zhao, D; Zhao, J | 1 |
1 other study(ies) available for 1-hydroxymethylmidazolam and 1-triacontanol
| Article | Year |
|---|---|
Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cytochrome P-450 CYP3A; Docetaxel; Enzyme Induction; Fatty Alcohols; Female; Gene Expression Regulation, Enzymologic; Male; Microsomes, Liver; Midazolam; Rats, Sprague-Dawley; Reproducibility of Results; Taxoids | 2014 |